share_log

Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.676%),Lincoln Park Capital, LLC(9.676%), etc.

Cellectar BioSciences | SC 13G/A:超过5%持股股东披露文件(修正)-Lincoln Park Capital Fund, LLC(9.676%),Lincoln Park Capital, LLC(9.676%)等

美股SEC公告 ·  02/14 16:35
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息